Fabrizio Vincenzi

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 24

Top Topics

Top Venues

International journal of molecular sciences

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Annalida Bedini, Gian Marco Elisi, Fabiola Fanini, Michele Retini, Laura Scalvini, Silvia Pasquini, Chiara Contri, Katia Varani, Gilberto Spadoni, Marco Mor, Fabrizio Vincenzi, Silvia Rivara
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence. Journal of pineal research 76 (2) (2024)
Elena Mariotto, Martina Canton, Chiara Marchioro, Andrea Brancale, Ernest Hamel, Katia Varani, Fabrizio Vincenzi, Tiziano De Ventura, Chiara Padroni, Giampietro Viola, Romeo Romagnoli
Synthesis and Biological Evaluation of Novel 2-Aroyl Benzofuran-Based Hydroxamic Acids as Antimicrotubule Agents. International journal of molecular sciences 25 (14) (2024)
Elena Mariotto, Martina Canton, Chiara Marchioro, Andrea Brancale, Ernest Hamel, Katia Varani, Fabrizio Vincenzi, Tiziano De Ventura, Chiara Padroni, Giampietro Viola, Romeo Romagnoli
Synthesis and Biological Evaluation of Novel 2-Aroyl Benzofuran-Based Hydroxamic Acids as Antimicrotubule Agents. International journal of molecular sciences 25 (14) (2024)
Elena Mariotto, Martina Canton, Chiara Marchioro, Andrea Brancale, Ernest Hamel, Katia Varani, Fabrizio Vincenzi, Tiziano De Ventura, Chiara Padroni, Giampietro Viola, Romeo Romagnoli
Synthesis and Biological Evaluation of Novel 2-Aroyl Benzofuran-Based Hydroxamic Acids as Antimicrotubule Agents. International journal of molecular sciences 25 (14) (2024)
Stefania Merighi, Alessia Travagli, Manuela Nigro, Silvia Pasquini, Martina Cappello, Chiara Contri, Katia Varani, Fabrizio Vincenzi, Pier Andrea Borea, Stefania Gessi
Caffeine for Prevention of Alzheimer's Disease: Is the A 2A Adenosine Receptor Its Target? Biomolecules 13 (6) (2023)
Teresa Gianferrara, Matteo Pavan, Davide Bassani, Fabrizio Vincenzi, Silvia Pasquini, Giovanni Bolcato, Katia Varani, Giampiero Spalluto, Stephanie Federico, Stefano Moro
Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors. ChemMedChem (2023)
Stefania Merighi, Alessia Travagli, Manuela Nigro, Silvia Pasquini, Martina Cappello, Chiara Contri, Katia Varani, Fabrizio Vincenzi, Pier Andrea Borea, Stefania Gessi
Caffeine for Prevention of Alzheimer's Disease: Is the A 2A Adenosine Receptor Its Target? Biomolecules 13 (6) (2023)
Mercedes Fernández, Manuela Nigro, Alessia Travagli, Silvia Pasquini, Fabrizio Vincenzi, Katia Varani, Pier Andrea Borea, Stefania Merighi, Stefania Gessi
Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy. Pharmaceutics 15 (10) (2023)
Stefania Merighi, Alessia Travagli, Manuela Nigro, Silvia Pasquini, Martina Cappello, Chiara Contri, Katia Varani, Fabrizio Vincenzi, Pier Andrea Borea, Stefania Gessi
Caffeine for Prevention of Alzheimer's Disease: Is the A 2A Adenosine Receptor Its Target? Biomolecules 13 (6) (2023)
Fabrizio Vincenzi, Silvia Pasquini, Chiara Contri, Martina Cappello, Manuela Nigro, Alessia Travagli, Stefania Merighi, Stefania Gessi, Pier Andrea Borea, Katia Varani
Pharmacology of Adenosine Receptors: Recent Advancements. Biomolecules 13 (9) (2023)
Alessandro Papa, Silvia Pasquini, Chiara Contri, Sandra Gemma, Giuseppe Campiani, Stefania Butini, Katia Varani, Fabrizio Vincenzi
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition. Cells 11 (3) (2022)
Chiara Domenicale, Daniela Mercatelli, Federica Albanese, Salvatore Novello, Fabrizio Vincenzi, Katia Varani, Michele Morari
Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice. Biomedicines 10 (4) (2022)
Micaela Tirri, Raffaella Arfè, Sabrine Bilel, Giorgia Corli, Beatrice Marchetti, Anna Fantinati, Fabrizio Vincenzi, Fabio De-Giorgio, Cristian Camuto, Monica Mazzarino, Mario Barbieri, Rosa Maria Gaudio, Katia Varani, Pier Andrea Borea, Francesco Botrè, Matteo Marti
In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice. International journal of molecular sciences 23 (14) (2022)
Daniela Catarzi, Flavia Varano, Erica Vigiani, Sara Calenda, Fabrizio Melani, Katia Varani, Fabrizio Vincenzi, Silvia Pasquini, Natascia Mennini, Giulia Nerli, Diego Dal Ben, Rosaria Volpini, Vittoria Colotta
4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives. Pharmaceuticals (Basel, Switzerland) 15 (4) (2022)
Stefania Merighi, Manuela Nigro, Alessia Travagli, Silvia Pasquini, Pier Andrea Borea, Katia Varani, Fabrizio Vincenzi, Stefania Gessi
A 2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity? International journal of molecular sciences 23 (9) (2022)
Stefania Merighi, Pier Andrea Borea, Katia Varani, Fabrizio Vincenzi, Alessia Travagli, Manuela Nigro, Silvia Pasquini, R Rama Suresh, Sung Won Kim, Nora D Volkow, Kenneth A Jacobson, Stefania Gessi
Pathophysiological Role and Medicinal Chemistry of A 2A Adenosine Receptor Antagonists in Alzheimer's Disease. Molecules (Basel, Switzerland) 27 (9) (2022)
Silvia Pasquini, Chiara Contri, Stefania Merighi, Stefania Gessi, Pier Andrea Borea, Katia Varani, Fabrizio Vincenzi
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets. International journal of molecular sciences 23 (3) (2022)
Silvia Pasquini, Chiara Contri, Pier Andrea Borea, Fabrizio Vincenzi, Katia Varani
Adenosine and Inflammation: Here, There and Everywhere. International journal of molecular sciences 22 (14) (2021)
Stefania Gessi, Tino Emanuele Poloni, Giulia Negro, Katia Varani, Silvia Pasquini, Fabrizio Vincenzi, Pier Andrea Borea, Stefania Merighi
A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease. Cells 10 (9) (2021)
Katia Varani, Fabrizio Vincenzi, Silvia Pasquini, Irene Blo, Simona Salati, Matteo Cadossi, Monica De Mattei
Pulsed Electromagnetic Field Stimulation in Osteogenesis and Chondrogenesis: Signaling Pathways and Therapeutic Implications. International journal of molecular sciences 22 (2) (2021)
Fabrizio Vincenzi, Silvia Pasquini, Pier Andrea Borea, Katia Varani
Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain. International journal of molecular sciences 21 (22) (2020)
Fabrizio Vincenzi, Silvia Pasquini, Stefania Gessi, Stefania Merighi, Romeo Romagnoli, Pier Andrea Borea, Katia Varani
The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A1AR Positive Allosteric Modulation. Cells 9 (5) (2020)
Fabrizio Vincenzi, Silvia Pasquini, Stefania Setti, Simona Salati, Ruggero Cadossi, Pier Andrea Borea, Katia Varani
Pulsed Electromagnetic Fields Stimulate HIF-1α-Independent VEGF Release in 1321N1 Human Astrocytes Protecting Neuron-Like SH-SY5Y Cells from Oxygen-Glucose Deprivation. International journal of molecular sciences 21 (21) (2020)
Daniela Catarzi, Flavia Varano, Katia Varani, Fabrizio Vincenzi, Silvia Pasquini, Diego Dal Ben, Rosaria Volpini, Vittoria Colotta
Amino-3,5-Dicyanopyridines Targeting the Adenosine Receptors Ranging from Pan Ligands to Combined A1/A2B Partial Agonists. Pharmaceuticals (Basel, Switzerland) 12 (4) (2019)